Cargando…
Emerging Biomarkers and Therapeutic Strategies for Refractory Bullous Pemphigoid
Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disorder in the elderly. Systemic and topical use of glucocorticoids and immunosuppressants has been shown to be effective in most patients. However, refractory BP patients are challenged to clinicians with severe clinical...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421646/ https://www.ncbi.nlm.nih.gov/pubmed/34504496 http://dx.doi.org/10.3389/fimmu.2021.718073 |